Fortitude Family Office, LLC Celldex Therapeutics, Inc. Transaction History
Fortitude Family Office, LLC
- $305 Billion
- Q2 2025
A detailed history of Fortitude Family Office, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 26 shares of CLDX stock, worth $597. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$597% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
189Shares Held
69.4MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$192 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$149 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$89.5 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$86.2 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.07B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...